Journal list Promote Sponsor
verified SJR 1,748 · Q1 • database Scopus / SJR & Web of Science indexed
Current Oncology Reports
United States · Current Science, Inc.
workspace_premium Q1 — Oncology lock_open Open Access

Current Oncology Reports

Current Oncology Reports provides in-depth review articles contributed by international experts on the most significant developments in the field. By presenting clear, insightful, balanced reviews that emphasize recently published papers of major importance, the journal serves a...

ISSN: 1523-3790
Publisher: Current Science, Inc.
Category: Oncology
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Visit publisher site menu_book Guidelines NPD
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
1,748 Q1
H-index 84
Acceptance rate pie_chart
28% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
3.190 € Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

1,748

H-index

84

Docs (year)

141

Docs 3y

455

Total refs

10898

Cites 3y

2520

Citable 3y

452

Cites/Doc 2y

5.05

Ref/Doc

77.29

Immediate OA

3190 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Epidemiology of Brain Metastases

Lakshmi Nayak Eudocia Quant Lee Patrick Y. Wen
936 Citations View more

The Obesity Paradox in Cancer: a Review

Hannah Lennon Matthew Sperrin Ellena Badrick
403 Citations View more

Obesity and Cancer Risk: Recent Review and Evidence

Karen Basen-Engquist Maria Chang
333 Citations View more

Updates on Management of Gastric Cancer

Fabian M. Johnston Michael Beckman
302 Citations View more

HIF Inhibitors: Status of Current Clinical Development

Jaleh Fallah Brian I. Rini
239 Citations View more

The role of C-reactive protein as a prognostic indicator in advanced cancer

Fade Aziz Mahmoud Nilo I. Rivera
229 Citations View more

The Gut Microbiome and Obesity

George Kunnackal John Gerard E. Mullin
229 Citations View more

The Impact of Obesity on Breast Cancer Diagnosis and Treatment

Kyuwan Lee Laura Kruper Christina M. Dieli-Conwright
222 Citations View more

Immune-Related Adverse Events (irAEs): Diagnosis, Management, and Clinical Pearls

Eli P. Darnell Meghan J. Mooradian Erez N. Baruch
218 Citations View more

Cancer-Promoting Effects of Microbial Dysbiosis

Amy M. Sheflin Alyssa K. Whitney Tiffany L. Weir
200 Citations View more

COVID-19 and Cancer: a Comprehensive Review

Rohit Gosain Yara Abdou Abhay Singh
199 Citations View more

Perifosine: Update on a novel Akt inhibitor

Joell J. Gills Phillip A. Dennis
186 Citations View more
SHOW MORE ARTICLES

VEGF Inhibition, Hypertension, and Renal Toxicity

Suzanne R. Hayman Nelson Leung Joseph P. Grande
182 Citations View more

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

Arthur M. Krieg
176 Citations View more

Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?

Satya Das Arvind Dasari
163 Citations View more

Integrins: Molecular targets in cancer therapy

Gordon C. Tucker
161 Citations View more

Melanoma and the tumor microenvironment

Jessie Villanueva Meenhard Herlyn
161 Citations View more

Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications

Daniella Karassawa Zanoni Snehal G. Patel Jatin P. Shah
160 Citations View more

Pazopanib: A novel multitargeted tyrosine kinase inhibitor

Guru Sonpavde Thomas E. Hutson
160 Citations View more

PI3K and mTOR Signaling Pathways in Cancer: New Data on Targeted Therapies

Lise Willems Jerome Tamburini Nicolas Chapuis
153 Citations View more

Emerging Variants of Castration-Resistant Prostate Cancer

Panagiotis J. Vlachostergios Loredana Puca Himisha Beltran
148 Citations View more

Clinical and Biological Features of Neuroendocrine Prostate Cancer

Yasutaka Yamada Himisha Beltran
139 Citations View more

PI3K Inhibitors in Breast Cancer Therapy

Haley Ellis Cynthia X. Ma
132 Citations View more

Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma

Camilo Jimenez Eric Rohren Mouhammed Amir Habra
130 Citations View more

FAQs